Learn how pregnancy medication safety alerts work, why data is limited, and what steps you can take to make informed decisions - without unnecessary fear or risky choices.
Learn how pregnancy medication safety alerts work, why data is limited, and what steps you can take to make informed decisions - without unnecessary fear or risky choices.
Monoclonal antibody biosimilars are highly similar, cost-effective alternatives to expensive biologic drugs like Herceptin and Rituxan. Approved for cancer and autoimmune conditions, they offer the same safety and effectiveness at a fraction of the cost-with billions in savings projected by 2028.
When your prescription switches to a generic drug, communication with your pharmacy can prevent side effects and ensure your treatment stays effective. Learn what to ask, when to speak up, and how to stay in control.
Pharmacists play a vital role in spotting and reporting adverse reactions to generic medications. Even small formulation differences can trigger serious side effects. Learn why reporting isn't optional-and how to do it effectively.
Learn how to use the FDA Orange Book to verify if a generic drug is therapeutically equivalent to its brand-name counterpart. Understand TE codes, search steps, common mistakes, and why this matters for safe substitutions.
Most patent disputes settle before trial, with companies negotiating licenses, cross-terms, or payouts to avoid costly litigation. Learn how real-world deals work, from Apple-Samsung to AI-powered settlement tools.
Bioequivalence testing for combination products like fixed-dose combos and drug-device systems is far more complex than for single drugs. Regulatory hurdles, inconsistent methods, and high costs delay generic access - but new modeling tools are starting to change that.
Low-dose CT screening can cut lung cancer deaths by 20%-but only if you qualify. Learn who should get screened, what results mean, and why so few eligible people actually do.
Learn how to read FDA safety announcements without panic. Understand the difference between potential signals and confirmed risks, how to assess real-world danger, and what steps to take when your medication is flagged.
Learn the key differences between osteoarthritis and rheumatoid arthritis - two of the most common types of joint disease. Understand causes, symptoms, treatments, and why misdiagnosis can be dangerous.
Osteonecrosis of the jaw from medications is rare but serious. Learn the key warning signs like exposed bone, delayed healing, and jaw pain-and how to prevent it if you're on bisphosphonates or denosumab.
Discover how generic medicines travel from raw ingredients to your local pharmacy. Learn about manufacturing, distribution, pricing challenges, and key stakeholders in the supply chain.